Skip to search formSkip to main contentSkip to account menu

CD 349

Known as: CD-349 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Effects of CD-349, a novel 1,4-dihydro-pyridine, and other calcium antagonists on membrane potentials in spontaneously beating… 
1993
1993
1. The metabolic fate of 14C-CD-349, a new calcium antagonist, was studied in rat and dog. 2. After oral administration of 14C… 
1993
1993
We have synthesized new 1,4-dihydropyridine derivatives having nitrooxyalkylester moieties at the 3- and 5-positions in order to… 
1992
1992
We investigated the effects of CD-349, a dihydropyridine derivative, on isoproterenol (Iso)-induced relaxation in rabbit aorta… 
1991
1991
Summary: We investigated the effects of nitroglycerin (NTG), atrial natriuretic peptide (ANP), and CD-349 on phorbol dibutyrate… 
1991
1991
We examined the calcium antagonistic action of CD-349, a dihydropyridine derivative, on goat cardiac Purkinje fibers using the… 
1990
1990
Summary: The effects of a Ca2+ entry blocker CD-349 and an intracellular Ca2+ release inhibitor TMB-8 on renal vasoconstriction… 
1988
1988
The binding to a Ca-channel of a novel 1,4-dihydropyridine (DHP) Ca-antagonist, 2-nitratopropyl 3-nitratopropyl 2,6-dimethyl-4-(3… 
1987
1987
CD-349 (2-nitratopropyl 3-nitratopropyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) inhibited the…